Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment interruption in HIV therapy: a SMART strategy?

B Jülg1, F D Goebel

  • 1Dept. of Infectious Diseases, Medical Policlinic, Ludwig Maximilian University Munich, Pettenkoferstrasse 8a, 80336 Munich, Germany.

Infection
|June 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel immunological strategies for HIV-1 eradication.

Journal of virus eradication·2016
Same author

Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2010
Same author

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.

Gene therapy·2010
Same author

Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.

Journal of virology·2010
Same author

Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.

European journal of medical research·2007
Same author

Clinical news from the XVI International AIDS Conference: The attempt of a summing up.

Infection·2006

Structured treatment interruptions for HIV therapy offer potential cost and side effect benefits. However, their safety and efficacy compared to continuous antiretroviral therapy (ART) require further investigation to clarify outcomes.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pharmacology

Background:

  • Highly Active Antiretroviral Therapy (HAART) is standard for HIV, but lifelong adherence and tolerance pose challenges.
  • Antiretroviral Therapy (ART) use carries risks including adverse events, metabolic/cardiovascular complications, and HIV resistance.
  • Stopping HIV therapy may reduce costs and side effects but risks immune suppression and resistance.

Purpose of the Study:

  • To compare the long-term consequences of continuous ART versus scheduled treatment interruptions.
  • To clarify clinical and biological factors influencing the outcomes of structured treatment interruptions.

Main Methods:

  • Review of recent studies comparing two antiretroviral management strategies.
  • Analysis of long-term consequences of continuous therapy versus scheduled treatment interruption.

Related Experiment Videos

Main Results:

  • Results of recent studies comparing continuous therapy and scheduled treatment interruption are presented.
  • The study aims to elucidate the long-term consequences of these two HIV management strategies.

Conclusions:

  • The safety and efficacy of structured treatment interruptions for HIV management are not yet established.
  • Further research is needed to fully understand the clinical and biological characteristics influencing treatment interruption outcomes.